Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342973 · ClinicalTrials.gov registry record · Phase 4
Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study
A Phase 4 study of Alveolar Ridge Deficiency, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06342973 is a Phase 4 study of Alveolar Ridge Deficiency that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06342973, a Phase 4 study of Alveolar Ridge Deficiency, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this case series is to evaluate the outcomes of horizontal ridge augmentation performed using a combination of demineralized freeze-dried bone allograft layered with xenograft bone with a resorbable native collagen membrane.
Conditions Studied
Interventions
- DEVICE Xenograft and allograft
Study Locations (1)
Louisiana
- LSUHSC School of Dentistry - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2025-10-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06342973
The ClinicalTrials.gov registry entry for NCT06342973 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alveolar Ridge Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Xenograft and allograft is the first listed.
NCT06342973 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06342973 about?
NCT06342973 is a clinical study titled "Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study". The aim of this case series is to evaluate the outcomes of horizontal ridge augmentation performed using a combination of demineralized freeze-dried bone allograft layered with xenograft bone with a resorbable native collagen membrane.
What is the current status of trial NCT06342973?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2024-03-27. Estimated completion is 2025-10-15.
What conditions does trial NCT06342973 study?
This clinical trial studies the following conditions: Alveolar Ridge Deficiency.
What interventions are being tested in trial NCT06342973?
The interventions under investigation include: Xenograft and allograft (DEVICE).
Who is sponsoring clinical trial NCT06342973?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342973 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.